Tobramycin
NDC Package 0409-3255-03

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Tobramycin is a medication used to treat eye infections. Marketed by Hospira, Inc., this product is identified by NDC 0409-3255 and is authorized under FDA application ANDA063080.

Identification & Billing

NDC Package Code
0409-3255-03
Package Description
25 VIAL, PATENT DELIVERY SYSTEM in 1 TRAY / 8 mL in 1 VIAL, PATENT DELIVERY SYSTEM
Product Code
0409-3255
11-Digit Billing Format
00409325503

Clinical Specifications

Proprietary Name
Tobramycin
Dosage Form
-
Usage Information
This medication is used to treat eye infections. Tobramycin belongs to a class of drugs called aminoglycoside antibiotics. It works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness.

Regulatory & Marketing

Labeler Name
Hospira, Inc.
FDA Application #
ANDA063080
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
04-30-1991
End Marketing Date
05-01-2010
Listing Expiration
05-01-2010
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0409-3255-03 identifies a specific commercial package of 25 vial, patent delivery system in 1 tray / 8 ml in 1 vial, patent delivery system of Tobramycin, labeled by Hospira, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Hospira, Inc. on April 30, 1991. The current certification is valid through May 01, 2010.

What are the primary indications for this medication?

This medication is used to treat eye infections. Tobramycin belongs to a class of drugs called aminoglycoside antibiotics. It works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness.

How is this Hospira, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00409325503. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0409-3255-03
11-Digit CMS (5-4-2)
00409-3255-03

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.